AI-generated summary
The authors studied 17 patients with dry eye disease from meibomian gland dysfunction who had not responded well to basic care, using a home light therapy mask over four sessions. They report improved tear film measures and lower ocular discomfort scores, with no adverse events and no significant change in gland loss. The study was prospective, but the abstract describes a small group without a control group.
- Participants
- 17
- Who or what was studied
- 17 adults (3 male, 14 female; mean age 61.47 years) with dry eye disease owing to meibomian gland dysfunction not responding to first-line therapy
- Limits stated in the abstract
- The abstract describes a small sample of 17 patients and does not mention a control group.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Low-level laser therapy, At-home device, Adverse event. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.